• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Clinical Data Utilizing the DRX9000(TM) Will Be Presented at the CONy in Athens, Greece!

Posted on: Friday, 10 October 2008, 18:00 CDT

Clinical data utilizing the DRX9000 True Non-Surgical Spinal Decompression System(TM) will be presented at the 2nd World Congress on Controversies in Neurology (CONy) in Athens, Greece October 23-26, 2008. The first study, is an IRB-approved, prospective multi-center phase II, non-randomized pilot study authored by Dr. John Leslie of the Mayo Clinic and others. This study was designed to evaluate the effectiveness and safety of the DRX9000 in treating chronic LBP (lower back pain). A greater than 50% reduction in pain score was observed after two weeks of treatment and upon completion of the entire six week protocol an amazing success rate of 88.9% was documented. Improvement of Oswestry scores and a decreased consumption of adjunctive pain medication were also noted. The second study, is retrospective data which included lumbar spine CT scans before and after patients were treated on the DRX9000 that demonstrates possible morphological changes associated with treatment. The authors conclude, "A significant reduction in chronic LBP after non-invasive spinal decompression correlated with an increase in disc height." One of the authors of the studies will be presenting the data at the 2nd World Congress CONy. Abstracts of both studies will be available. These presentations represent an effort to further educate the International Community on the effectiveness of our products.

Non-treatment or control groups were not included making efficacy outcome versus placebo or spontaneous recovery difficult to determine. Randomized double-blinded or comparative long-term outcome trials are needed to further prove the efficacy of non-surgical spinal decompression systems such as the DRX9000(TM) for the routine treatment of chronic LBP. This study was partially funded by Axiom Worldwide.

A randomized controlled trial is needed to prove that restoration in disc height is the mechanism through which non-surgical spinal decompression systems such as the DRX9000(TM) leads to these impressive reductions in pain.

Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-surgical Spinal Decompression System(TM), DRX9000C(TM), and DRX9500(TM) in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000(TM), for use in relieving pain and for use in muscular rehabilitation. Axiom prides itself on providing safe, non-surgical alternatives that patients should consider prior to undergoing surgery. For additional information please visit: www.AxiomWorldwide.com. To schedule an interview please contact: Amber Pacetti, Marketing at: telephone: 001-813-249-6444 or email: apacetti@axiomworldwide.com.

Source: Business Wire

More News in this Category